Global Prescription Gastrointestinal Drugs Market Growth 2025-2031

December 2025 | 91 pages | ID: GB3A419625BEN
LP Information

Abstracts

The global Prescription Gastrointestinal Drugs market size is predicted to grow from US$ 32490 million in 2025 to US$ 45070 million in 2031; it is expected to grow at a CAGR of 5.6% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

The prescription drugs are widely used in the treatment of gastrointestinal disorders, crohn’s disease, ulcerative colitis, irritable bowel syndrome, diverticular disease, constipation, celiac disease, short bowel syndrome, diarrhea, intestinal obstruction and digestive enzyme disorders.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ' newest research report, the “Prescription Gastrointestinal Drugs Industry Forecast” looks at past sales and reviews total world Prescription Gastrointestinal Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Prescription Gastrointestinal Drugs sales for 2025 through 2031. With Prescription Gastrointestinal Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prescription Gastrointestinal Drugs industry.

This Insight Report provides a comprehensive analysis of the global Prescription Gastrointestinal Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Prescription Gastrointestinal Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Prescription Gastrointestinal Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prescription Gastrointestinal Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prescription Gastrointestinal Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Prescription Gastrointestinal Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Oral
• Topical

Segmentation by Application:

• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• AstraZeneca
• Axcan Pharmaceuticals
• Eisai
• GlaxoSmithKline
• Merck
• Salix Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Prescription Gastrointestinal Drugs market?

What factors are driving Prescription Gastrointestinal Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Prescription Gastrointestinal Drugs market opportunities vary by end market size?

How does Prescription Gastrointestinal Drugs break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Prescription Gastrointestinal Drugs Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Prescription Gastrointestinal Drugs by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Prescription Gastrointestinal Drugs by Country/Region, 2020, 2024 & 2031
2.2 Prescription Gastrointestinal Drugs Segment by Type
  2.2.1 Oral
  2.2.2 Topical
2.3 Prescription Gastrointestinal Drugs Sales by Type
  2.3.1 Global Prescription Gastrointestinal Drugs Sales Market Share by Type (2020-2025)
  2.3.2 Global Prescription Gastrointestinal Drugs Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Prescription Gastrointestinal Drugs Sale Price by Type (2020-2025)
2.4 Prescription Gastrointestinal Drugs Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Online Pharmacies
  2.4.3 Retail Pharmacies
2.5 Prescription Gastrointestinal Drugs Sales by Application
  2.5.1 Global Prescription Gastrointestinal Drugs Sale Market Share by Application (2020-2025)
  2.5.2 Global Prescription Gastrointestinal Drugs Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Prescription Gastrointestinal Drugs Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Prescription Gastrointestinal Drugs Breakdown Data by Company
  3.1.1 Global Prescription Gastrointestinal Drugs Annual Sales by Company (2020-2025)
  3.1.2 Global Prescription Gastrointestinal Drugs Sales Market Share by Company (2020-2025)
3.2 Global Prescription Gastrointestinal Drugs Annual Revenue by Company (2020-2025)
  3.2.1 Global Prescription Gastrointestinal Drugs Revenue by Company (2020-2025)
  3.2.2 Global Prescription Gastrointestinal Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Prescription Gastrointestinal Drugs Sale Price by Company
3.4 Key Manufacturers Prescription Gastrointestinal Drugs Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Prescription Gastrointestinal Drugs Product Location Distribution
  3.4.2 Players Prescription Gastrointestinal Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR PRESCRIPTION GASTROINTESTINAL DRUGS BY GEOGRAPHIC REGION

4.1 World Historic Prescription Gastrointestinal Drugs Market Size by Geographic Region (2020-2025)
  4.1.1 Global Prescription Gastrointestinal Drugs Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Prescription Gastrointestinal Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Prescription Gastrointestinal Drugs Market Size by Country/Region (2020-2025)
  4.2.1 Global Prescription Gastrointestinal Drugs Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Prescription Gastrointestinal Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Prescription Gastrointestinal Drugs Sales Growth
4.4 APAC Prescription Gastrointestinal Drugs Sales Growth
4.5 Europe Prescription Gastrointestinal Drugs Sales Growth
4.6 Middle East & Africa Prescription Gastrointestinal Drugs Sales Growth

5 AMERICAS

5.1 Americas Prescription Gastrointestinal Drugs Sales by Country
  5.1.1 Americas Prescription Gastrointestinal Drugs Sales by Country (2020-2025)
  5.1.2 Americas Prescription Gastrointestinal Drugs Revenue by Country (2020-2025)
5.2 Americas Prescription Gastrointestinal Drugs Sales by Type (2020-2025)
5.3 Americas Prescription Gastrointestinal Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Prescription Gastrointestinal Drugs Sales by Region
  6.1.1 APAC Prescription Gastrointestinal Drugs Sales by Region (2020-2025)
  6.1.2 APAC Prescription Gastrointestinal Drugs Revenue by Region (2020-2025)
6.2 APAC Prescription Gastrointestinal Drugs Sales by Type (2020-2025)
6.3 APAC Prescription Gastrointestinal Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Prescription Gastrointestinal Drugs by Country
  7.1.1 Europe Prescription Gastrointestinal Drugs Sales by Country (2020-2025)
  7.1.2 Europe Prescription Gastrointestinal Drugs Revenue by Country (2020-2025)
7.2 Europe Prescription Gastrointestinal Drugs Sales by Type (2020-2025)
7.3 Europe Prescription Gastrointestinal Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Prescription Gastrointestinal Drugs by Country
  8.1.1 Middle East & Africa Prescription Gastrointestinal Drugs Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Prescription Gastrointestinal Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Prescription Gastrointestinal Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Prescription Gastrointestinal Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Prescription Gastrointestinal Drugs
10.3 Manufacturing Process Analysis of Prescription Gastrointestinal Drugs
10.4 Industry Chain Structure of Prescription Gastrointestinal Drugs

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Prescription Gastrointestinal Drugs Distributors
11.3 Prescription Gastrointestinal Drugs Customer

12 WORLD FORECAST REVIEW FOR PRESCRIPTION GASTROINTESTINAL DRUGS BY GEOGRAPHIC REGION

12.1 Global Prescription Gastrointestinal Drugs Market Size Forecast by Region
  12.1.1 Global Prescription Gastrointestinal Drugs Forecast by Region (2026-2031)
  12.1.2 Global Prescription Gastrointestinal Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Prescription Gastrointestinal Drugs Forecast by Type (2026-2031)
12.7 Global Prescription Gastrointestinal Drugs Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 AstraZeneca
  13.1.1 AstraZeneca Company Information
  13.1.2 AstraZeneca Prescription Gastrointestinal Drugs Product Portfolios and Specifications
  13.1.3 AstraZeneca Prescription Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 AstraZeneca Main Business Overview
  13.1.5 AstraZeneca Latest Developments
13.2 Axcan Pharmaceuticals
  13.2.1 Axcan Pharmaceuticals Company Information
  13.2.2 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Product Portfolios and Specifications
  13.2.3 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Axcan Pharmaceuticals Main Business Overview
  13.2.5 Axcan Pharmaceuticals Latest Developments
13.3 Eisai
  13.3.1 Eisai Company Information
  13.3.2 Eisai Prescription Gastrointestinal Drugs Product Portfolios and Specifications
  13.3.3 Eisai Prescription Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Eisai Main Business Overview
  13.3.5 Eisai Latest Developments
13.4 GlaxoSmithKline
  13.4.1 GlaxoSmithKline Company Information
  13.4.2 GlaxoSmithKline Prescription Gastrointestinal Drugs Product Portfolios and Specifications
  13.4.3 GlaxoSmithKline Prescription Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 GlaxoSmithKline Main Business Overview
  13.4.5 GlaxoSmithKline Latest Developments
13.5 Merck
  13.5.1 Merck Company Information
  13.5.2 Merck Prescription Gastrointestinal Drugs Product Portfolios and Specifications
  13.5.3 Merck Prescription Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Merck Main Business Overview
  13.5.5 Merck Latest Developments
13.6 Salix Pharmaceuticals
  13.6.1 Salix Pharmaceuticals Company Information
  13.6.2 Salix Pharmaceuticals Prescription Gastrointestinal Drugs Product Portfolios and Specifications
  13.6.3 Salix Pharmaceuticals Prescription Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Salix Pharmaceuticals Main Business Overview
  13.6.5 Salix Pharmaceuticals Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Prescription Gastrointestinal Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Prescription Gastrointestinal Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Topical
Table 5. Global Prescription Gastrointestinal Drugs Sales by Type (2020-2025) & (K Units)
Table 6. Global Prescription Gastrointestinal Drugs Sales Market Share by Type (2020-2025)
Table 7. Global Prescription Gastrointestinal Drugs Revenue by Type (2020-2025) & ($ million)
Table 8. Global Prescription Gastrointestinal Drugs Revenue Market Share by Type (2020-2025)
Table 9. Global Prescription Gastrointestinal Drugs Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Prescription Gastrointestinal Drugs Sale by Application (2020-2025) & (K Units)
Table 11. Global Prescription Gastrointestinal Drugs Sale Market Share by Application (2020-2025)
Table 12. Global Prescription Gastrointestinal Drugs Revenue by Application (2020-2025) & ($ million)
Table 13. Global Prescription Gastrointestinal Drugs Revenue Market Share by Application (2020-2025)
Table 14. Global Prescription Gastrointestinal Drugs Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Prescription Gastrointestinal Drugs Sales by Company (2020-2025) & (K Units)
Table 16. Global Prescription Gastrointestinal Drugs Sales Market Share by Company (2020-2025)
Table 17. Global Prescription Gastrointestinal Drugs Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Prescription Gastrointestinal Drugs Revenue Market Share by Company (2020-2025)
Table 19. Global Prescription Gastrointestinal Drugs Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Prescription Gastrointestinal Drugs Producing Area Distribution and Sales Area
Table 21. Players Prescription Gastrointestinal Drugs Products Offered
Table 22. Prescription Gastrointestinal Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Prescription Gastrointestinal Drugs Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Prescription Gastrointestinal Drugs Sales Market Share Geographic Region (2020-2025)
Table 27. Global Prescription Gastrointestinal Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Prescription Gastrointestinal Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Prescription Gastrointestinal Drugs Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Prescription Gastrointestinal Drugs Sales Market Share by Country/Region (2020-2025)
Table 31. Global Prescription Gastrointestinal Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Prescription Gastrointestinal Drugs Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Prescription Gastrointestinal Drugs Sales by Country (2020-2025) & (K Units)
Table 34. Americas Prescription Gastrointestinal Drugs Sales Market Share by Country (2020-2025)
Table 35. Americas Prescription Gastrointestinal Drugs Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Prescription Gastrointestinal Drugs Sales by Type (2020-2025) & (K Units)
Table 37. Americas Prescription Gastrointestinal Drugs Sales by Application (2020-2025) & (K Units)
Table 38. APAC Prescription Gastrointestinal Drugs Sales by Region (2020-2025) & (K Units)
Table 39. APAC Prescription Gastrointestinal Drugs Sales Market Share by Region (2020-2025)
Table 40. APAC Prescription Gastrointestinal Drugs Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Prescription Gastrointestinal Drugs Sales by Type (2020-2025) & (K Units)
Table 42. APAC Prescription Gastrointestinal Drugs Sales by Application (2020-2025) & (K Units)
Table 43. Europe Prescription Gastrointestinal Drugs Sales by Country (2020-2025) & (K Units)
Table 44. Europe Prescription Gastrointestinal Drugs Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Prescription Gastrointestinal Drugs Sales by Type (2020-2025) & (K Units)
Table 46. Europe Prescription Gastrointestinal Drugs Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Prescription Gastrointestinal Drugs Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Prescription Gastrointestinal Drugs Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Prescription Gastrointestinal Drugs Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Prescription Gastrointestinal Drugs Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Prescription Gastrointestinal Drugs
Table 52. Key Market Challenges & Risks of Prescription Gastrointestinal Drugs
Table 53. Key Industry Trends of Prescription Gastrointestinal Drugs
Table 54. Prescription Gastrointestinal Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Prescription Gastrointestinal Drugs Distributors List
Table 57. Prescription Gastrointestinal Drugs Customer List
Table 58. Global Prescription Gastrointestinal Drugs Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Prescription Gastrointestinal Drugs Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Prescription Gastrointestinal Drugs Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Prescription Gastrointestinal Drugs Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Prescription Gastrointestinal Drugs Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Prescription Gastrointestinal Drugs Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Prescription Gastrointestinal Drugs Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Prescription Gastrointestinal Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Prescription Gastrointestinal Drugs Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Prescription Gastrointestinal Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Prescription Gastrointestinal Drugs Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Prescription Gastrointestinal Drugs Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Prescription Gastrointestinal Drugs Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Prescription Gastrointestinal Drugs Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. AstraZeneca Basic Information, Prescription Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. AstraZeneca Prescription Gastrointestinal Drugs Product Portfolios and Specifications
Table 74. AstraZeneca Prescription Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. AstraZeneca Main Business
Table 76. AstraZeneca Latest Developments
Table 77. Axcan Pharmaceuticals Basic Information, Prescription Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Product Portfolios and Specifications
Table 79. Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Axcan Pharmaceuticals Main Business
Table 81. Axcan Pharmaceuticals Latest Developments
Table 82. Eisai Basic Information, Prescription Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Eisai Prescription Gastrointestinal Drugs Product Portfolios and Specifications
Table 84. Eisai Prescription Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Eisai Main Business
Table 86. Eisai Latest Developments
Table 87. GlaxoSmithKline Basic Information, Prescription Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. GlaxoSmithKline Prescription Gastrointestinal Drugs Product Portfolios and Specifications
Table 89. GlaxoSmithKline Prescription Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. GlaxoSmithKline Main Business
Table 91. GlaxoSmithKline Latest Developments
Table 92. Merck Basic Information, Prescription Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Merck Prescription Gastrointestinal Drugs Product Portfolios and Specifications
Table 94. Merck Prescription Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Merck Main Business
Table 96. Merck Latest Developments
Table 97. Salix Pharmaceuticals Basic Information, Prescription Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Salix Pharmaceuticals Prescription Gastrointestinal Drugs Product Portfolios and Specifications
Table 99. Salix Pharmaceuticals Prescription Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Salix Pharmaceuticals Main Business
Table 101. Salix Pharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Prescription Gastrointestinal Drugs
Figure 2. Prescription Gastrointestinal Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Prescription Gastrointestinal Drugs Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Prescription Gastrointestinal Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Prescription Gastrointestinal Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Prescription Gastrointestinal Drugs Sales Market Share by Country/Region (2024)
Figure 10. Prescription Gastrointestinal Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Oral
Figure 12. Product Picture of Topical
Figure 13. Global Prescription Gastrointestinal Drugs Sales Market Share by Type in 2025
Figure 14. Global Prescription Gastrointestinal Drugs Revenue Market Share by Type (2020-2025)
Figure 15. Prescription Gastrointestinal Drugs Consumed in Hospital Pharmacies
Figure 16. Global Prescription Gastrointestinal Drugs Market: Hospital Pharmacies (2020-2025) & (K Units)
Figure 17. Prescription Gastrointestinal Drugs Consumed in Online Pharmacies
Figure 18. Global Prescription Gastrointestinal Drugs Market: Online Pharmacies (2020-2025) & (K Units)
Figure 19. Prescription Gastrointestinal Drugs Consumed in Retail Pharmacies
Figure 20. Global Prescription Gastrointestinal Drugs Market: Retail Pharmacies (2020-2025) & (K Units)
Figure 21. Global Prescription Gastrointestinal Drugs Sale Market Share by Application (2024)
Figure 22. Global Prescription Gastrointestinal Drugs Revenue Market Share by Application in 2025
Figure 23. Prescription Gastrointestinal Drugs Sales by Company in 2025 (K Units)
Figure 24. Global Prescription Gastrointestinal Drugs Sales Market Share by Company in 2025
Figure 25. Prescription Gastrointestinal Drugs Revenue by Company in 2025 ($ millions)
Figure 26. Global Prescription Gastrointestinal Drugs Revenue Market Share by Company in 2025
Figure 27. Global Prescription Gastrointestinal Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Prescription Gastrointestinal Drugs Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Prescription Gastrointestinal Drugs Sales 2020-2025 (K Units)
Figure 30. Americas Prescription Gastrointestinal Drugs Revenue 2020-2025 ($ millions)
Figure 31. APAC Prescription Gastrointestinal Drugs Sales 2020-2025 (K Units)
Figure 32. APAC Prescription Gastrointestinal Drugs Revenue 2020-2025 ($ millions)
Figure 33. Europe Prescription Gastrointestinal Drugs Sales 2020-2025 (K Units)
Figure 34. Europe Prescription Gastrointestinal Drugs Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Prescription Gastrointestinal Drugs Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Prescription Gastrointestinal Drugs Revenue 2020-2025 ($ millions)
Figure 37. Americas Prescription Gastrointestinal Drugs Sales Market Share by Country in 2025
Figure 38. Americas Prescription Gastrointestinal Drugs Revenue Market Share by Country (2020-2025)
Figure 39. Americas Prescription Gastrointestinal Drugs Sales Market Share by Type (2020-2025)
Figure 40. Americas Prescription Gastrointestinal Drugs Sales Market Share by Application (2020-2025)
Figure 41. United States Prescription Gastrointestinal Drugs Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Prescription Gastrointestinal Drugs Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Prescription Gastrointestinal Drugs Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Prescription Gastrointestinal Drugs Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Prescription Gastrointestinal Drugs Sales Market Share by Region in 2025
Figure 46. APAC Prescription Gastrointestinal Drugs Revenue Market Share by Region (2020-2025)
Figure 47. APAC Prescription Gastrointestinal Drugs Sales Market Share by Type (2020-2025)
Figure 48. APAC Prescription Gastrointestinal Drugs Sales Market Share by Application (2020-2025)
Figure 49. China Prescription Gastrointestinal Drugs Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Prescription Gastrointestinal Drugs Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Prescription Gastrointestinal Drugs Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Prescription Gastrointestinal Drugs Revenue Growth 2020-2025 ($ millions)
Figure 53. India Prescription Gastrointestinal Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Prescription Gastrointestinal Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Prescription Gastrointestinal Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Prescription Gastrointestinal Drugs Sales Market Share by Country in 2025
Figure 57. Europe Prescription Gastrointestinal Drugs Revenue Market Share by Country (2020-2025)
Figure 58. Europe Prescription Gastrointestinal Drugs Sales Market Share by Type (2020-2025)
Figure 59. Europe Prescription Gastrointestinal Drugs Sales Market Share by Application (2020-2025)
Figure 60. Germany Prescription Gastrointestinal Drugs Revenue Growth 2020-2025 ($ millions)
Figure 61. France Prescription Gastrointestinal Drugs Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Prescription Gastrointestinal Drugs Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Prescription Gastrointestinal Drugs Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Prescription Gastrointestinal Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Prescription Gastrointestinal Drugs Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Prescription Gastrointestinal Drugs Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Prescription Gastrointestinal Drugs Sales Market Share by Application (2020-2025)
Figure 68. Egypt Prescription Gastrointestinal Drugs Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Prescription Gastrointestinal Drugs Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Prescription Gastrointestinal Drugs Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Prescription Gastrointestinal Drugs Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Prescription Gastrointestinal Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Prescription Gastrointestinal Drugs in 2025
Figure 74. Manufacturing Process Analysis of Prescription Gastrointestinal Drugs
Figure 75. Industry Chain Structure of Prescription Gastrointestinal Drugs
Figure 76. Channels of Distribution
Figure 77. Global Prescription Gastrointestinal Drugs Sales Market Forecast by Region (2026-2031)
Figure 78. Global Prescription Gastrointestinal Drugs Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Prescription Gastrointestinal Drugs Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Prescription Gastrointestinal Drugs Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Prescription Gastrointestinal Drugs Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Prescription Gastrointestinal Drugs Revenue Market Share Forecast by Application (2026-2031)